Involvement of the SKP2-p27 KIP1 pathway in suppression of cancer cell proliferation by RECK

Oncogene

Volumn 31, Issue 37, 2012, Pages 4128-4138

  Yoshida, Y ^a   Ninomiya, K ^a   Hamada, H ^b   Noda, M ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

cell cycle; collagen; extracellular matrix; p27; RECK; SKP2

Indexed keywords

COLLAGEN TYPE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; RECK PROTEIN; REGULATOR PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE LEVEL; UPREGULATION;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; GPI-LINKED PROTEINS; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; UP-REGULATION;

EID: 84866353528     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.570     Document Type: Article

References (40)

1. Bond M, Wu YJ, Sala-Newby GB, Newby AC. (2008). Rho GTPase, Rac1, regulates SKP2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo. Cardiovasc Res 80: 290-298.
2. Caswell PT, Vadrevu S, Norman JC. (2009). Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 10: 843-853.
3. Chandana EP, Maeda Y, Ueda A, Kiyonari H, Oshima N, Yamamoto M et al. (2010). Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice. BMC Dev Biol 10: 84.
4. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
5. Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, Moller K et al. (2004). Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64: 4040-4048. (Pubitemid 38697320)
6. Frescas D, Pagano M. (2008). Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8: 438-449. (Pubitemid 351744963)
7. Freshney RI. (1987). Disaggregation of the tissue and primary culture. Culture of animal cells: A manual of basic technique 2nd edn. Wiley-Liss, Inc.: New York, pp 117-118.
8. Fu Y, Fang Z, Liang Y, Zhu X, Prins P, Li Z et al. (2007). Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing SKP2-dependent degradation of p27 via PI3K pathway. J Cell Biochem 102: 704-718. (Pubitemid 47557423)
9. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ et al. (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation. J Biol Chem 271: 695-701.
10. Hatta M, Matsuzaki T, Morioka Y, Yoshida Y, Noda M. (2009). Density-and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts. Cell Signal 21: 1885-1893.
11. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. (1995). Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503.
12. Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J et al. (2007). Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci 120: 849-857. (Pubitemid 46523486)
13. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A et al. (2008). Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 3: e1651.
14. Leibovitz A, Stinson JC, McCombs 3rd WB, McCoy CE, Mazur KC, Mabry ND. (1976). Classification of human colorectal adenocarci-noma cell lines. Cancer Res 36: 4562-4569.
15. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH et al. (2010). SKP2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 464: 374-379.
16. Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, Noda M. (2010). Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 29: 2638-2648.
17. Miki T, Takegami Y, Okawa K, Muraguchi T, Noda M, Takahashi C. (2007). The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metallopro-teinase and CD13/aminopeptidase N and modulates their endocytic pathways. J Biol Chem 282: 12341-12352. (Pubitemid 47100672)
18. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K et al. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93: 1320-1324.
19. Morioka Y, Monypenny J, Matsuzaki T, Shi S, Alexander DB, Kitayama H et al. (2009). The membrane-anchored metalloprotei-nase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts. Oncogene 28: 1454-1464.
20. Muraguchi T, Takegami Y, Ohtsuka T, Kitajima S, Chandana EP, Omura A et al. (2007). RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci 10: 838-845. (Pubitemid 47013438)
21. Murai R, Yoshida Y, Muraguchi T, Nishimoto E, Morioka Y, Kitayama H et al. (2010). A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs. Oncotarget 1: 252-264.
22. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K et al. (2000). Targeted disruption of SKP2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 19: 2069-2081. (Pubitemid 30237582)
23. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S et al. (2004). SKP2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6: 661-672. (Pubitemid 38579350)
24. Noda M, Kitayama H, Matsuzaki T, Sugimoto Y, Okayama H, Bassin RH et al. (1989). Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci USA 86: 162-166. (Pubitemid 19036348)
25. Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C. (2003). RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22: 167-175. (Pubitemid 36561056)
26. Noda M, Selinger Z, Scolnick EM, Bassin RH. (1983). Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc Natl Acad Sci USA 80: 5602-5606. (Pubitemid 14242892)
27. Noda M, Takahashi C. (2007). Recklessness as a hallmark of aggressive cancer. Cancer Sci 98: 1659-1665. (Pubitemid 47487898)
28. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM et al. (2001). The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789-800. (Pubitemid 34033671)
29. Omura A, Matsuzaki T, Mio K, Ogura T, Yamamoto M, Fujita A et al. (2009). RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase- catalyzed cleavage of fibronectin. J Biol Chem 284: 3461-3469.
30. Prifti E, Zucker JD, Clement K, Henegar C. (2008). FunNet: an integrative tool for exploring transcriptional interactions. Bioinfor-matics 24: 2636-2638.
31. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB. (1974). Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33: 1027-1033.
32. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H et al. (2007). Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
33. Sasahara RM, Takahashi C, Noda M. (1999). Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun 264: 668-675.
34. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602. (Pubitemid 27152402)
35. Sternlicht MD, Werb Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 17: 463-516. (Pubitemid 33096184)
36. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K et al. (1998). Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221-13226. (Pubitemid 28509552)
37. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M et al. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781. (Pubitemid 21907725)
38. Yoshida Y, Hamada H. (1997). Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem Biophys Res Commun 230: 426-430. (Pubitemid 27212014)
39. Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Hisatomi A et al. (2003). Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2. Hepatology 38: 305-313. (Pubitemid 36919851)
40. Zhu L. (2010). SKP2 knockout reduces cell proliferation and mouse body size: and prevents cancer? Cell Res 20: 605-607.